Vedolizumab Proves Its Worth in Treating Chronic Pouchitis
(MedPage Today) -- Vedolizumab (Entyvio) was more effective at inducing remission in patients with chronic pouchitis after ileal pouch-anal anastomosis (IPAA) for ulcerative colitis compared with placebo, a randomized phase IV trial showed.
Among... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 29, 2023 Category: Gastroenterology Source Type: news
High EHR Burden for Some GI Providers High EHR Burden for Some GI Providers
EHR use may be particularly burdensome for physicians who specialize in inflammatory bowel disease or hepatology, as well as for nonphysician GI care providers.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 29, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
U.S. sues Walmart for firing deli worker with Crohn's disease
Walmart Inc has been sued by the U.S. Equal Employment Opportunity Commission (EEOC), which on Tuesday accused the largest U.S. retailer of illegally firing a North Carolina deli worker with Crohn's disease. The EEOC said Walmart violated the Americans with Disabilities Act by dismissing Adrian…#walmartinc #eeoc #northcarolina #crohn #walmart #adriantucker #charlotte #statesville #melindadugas #bentonville (Source: Reuters: Health)
Source: Reuters: Health - March 28, 2023 Category: Consumer Health News Source Type: news
Peninsula cell therapy company lands big deal with Regeneron
While most cell therapy companies target cancer, Sonoma Bio is hitting autoimmune and inflammatory diseases, including rheumatoid arthritis, ulcerative colitis and more. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - March 28, 2023 Category: American Health Authors: Ron Leuty Source Type: news
Ustekinumab Effectiveness and Safety in Ulcerative Colitis Ustekinumab Effectiveness and Safety in Ulcerative Colitis
Does the effectiveness and safety of ustekinumab seen in clinical trials translate to real-world clinical outcomes?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 23, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Episode 3: Pregnancy, Fertility, Ulcerative Colitis: Facts vs Fiction Episode 3: Pregnancy, Fertility, Ulcerative Colitis: Facts vs Fiction
Join Drs Sunanda Kane and Uma Mahadevan as they set out to separate fact from fiction when treating patients with ulcerative colitis before, during, and after pregnancy.Medscape (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - March 21, 2023 Category: Surgery Tags: Gastroenterology InDiscussion Source Type: news
Comparing Tofacitinib and Vedolizumab in Ulcerative Colitis Comparing Tofacitinib and Vedolizumab in Ulcerative Colitis
Which of these two drugs is the most effective option for ulcerative colitis patients who previously failed anti-TNF treatment?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 21, 2023 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
‘We’ll look back and say that this was a bargain.’ Takeda reveals first data from its $4 billion autoimmune disease pill
In an intermediate-stage clinical study of 259 people with moderate-to-severe plaque psoriasis, the highest dose of the daily pill completely cleared itchy and painful patches of skin in one-third of the patients after 12 weeks. “We’re offering the potential for a functional cure,” Andrew Plump,…#andrewplump #takeda #boston #nimbustherapeutics #neworleans #plump #crohns #nimbus #tyk2 #bristolmyerssquibb (Source: Reuters: Health)
Source: Reuters: Health - March 18, 2023 Category: Consumer Health News Source Type: news
Clinical Guideline Developed for Use of Biomarkers in Ulcerative Colitis
FRIDAY, March 17, 2023 -- In a clinical practice guideline issued by the American Gastroenterological Association and published in the March issue of Gastroenterology, recommendations are presented for the role of biomarkers in the management of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 17, 2023 Category: Pharmaceuticals Source Type: news
TREMFYA ® (guselkumab) Real-World Data Analyses Show Greater Treatment Persistence Than IL-17s in Both Bio-naïve and Bio-experienced Patients Living With Moderate to Severe Plaque Psoriasis
SPRING HOUSE, PENNSYLVANIA, March 17, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new data, showing that initiation of TREMFYA® (guselkumab) was associated with greater treatment persistencea compared to secukinumab or ixekizumab in bio-naïve and bio-experienced patientsb living with moderate to severe plaque psoriasis (PsO), based on pairwise analysesc of real-world data.[1],[2] Additionally, in a post-hoc analysis of Phase 3 VOYAGE 2 clinical trial results, TREMFYA demonstrated durable clinical efficacy, itch relief and quality-of-life improvements in patients living with scal...
Source: Johnson and Johnson - March 17, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Have IBD and Insomnia? You're Not Alone Have IBD and Insomnia? You're Not Alone
More than one third of people with inflammatory bowel disease report trouble sleeping, with moderate or worse insomnia.WebMD Health News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 16, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Upadacitinib Shows Positive Endoscopic Outcomes in Crohn's Disease Upadacitinib Shows Positive Endoscopic Outcomes in Crohn's Disease
Already FDA approved for ulcerative colitis, upadacitinib improves endoscopic response versus placebo in people with Crohn ' s disease, research shows.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 16, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
Have IBD and Insomnia? You ’re Not Alone
More than one-third of people with inflammatory bowel disease report trouble sleeping, with moderate or worse insomnia. And the more severe their insomnia, the worse the disability related to their IBD, a new study finds. (Source: WebMD Health)
Source: WebMD Health - March 16, 2023 Category: Consumer Health News Source Type: news
Ulcerative Colitis Cases Projected to Top 2 Million by 2031 Ulcerative Colitis Cases Projected to Top 2 Million by 2031
Diagnosed prevalent cases of ulcerative colitis in eight countries will top 2 million in 2031, with the United States having the most cases, according to newly released projections.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 16, 2023 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
AI Helps Predict Ulcerative Colitis Remission/Activity, Flare-ups AI Helps Predict Ulcerative Colitis Remission/Activity, Flare-ups
An AI tool can distinguish histological remission from activity in biopsies of UC and predict flare-ups -- and could have a role in both clinical trials and routine practice.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 14, 2023 Category: Gastroenterology Tags: Gastroenterology News Source Type: news
